Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 2Myasthenia Gravis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Glioblastoma 1

Interventions

Etanercept 12Adalimumab 12Infliximab 7golimumab 4Tumor Necrosis Factor Inhibitors 4Certolizumab Pegol 4Abatacept 4tofacitinib 2tocilizumab 2Rituximab 2Antirheumatic Agents 2Vitamin D 1Vaccines 1Syringes 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Saline Solution 1Radioimmunodetection 1Prednisone 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Nivolumab 1Methotrexate 1Methods 1Lysine Acetyltransferase 5 1Licensure 1Leflunomide 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Arthritis, Rheumatoid × tofacitinib × Clear all
NCT03976245 2024-11-29

Advanced Therapeutics in Rheumatoid Arthritis (RA)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 4 Recruiting
144 enrolled

Arthritis, Rheumatoid

NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡